Combination therapy of IFN plus IL-2 for patients with mRCC after failed molecular targeted therapy
Not Applicable
- Conditions
- advaned RCC
- Registration Number
- JPRN-UMIN000015695
- Lead Sponsor
- Osaka Medical College
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
Not provided
Exclusion Criteria
-allergy for IFN or IL-2 -allergy for any vaccine -Patient using Shosaikoto (Ref. Std. Kampo Nomenclature). -Auto-immune disease -interstitial pneumonia -pregnant -long lasting steroids usage -brain mets -any pts doctor felt unfit the trial
Study & Design
- Study Type
- Interventional,observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method